A Phase 2 Clinical Study of MM-151 in Patients with Colorectal Cancer
Phase of Trial: Phase II
Latest Information Update: 10 Aug 2015
Price : $35 *
At a glance
- Drugs MM-151 (Primary)
- Indications Colorectal cancer; Solid tumours
- Focus Biomarker; Therapeutic Use
- 10 Aug 2015 Merrimack Pharmaceuticals anticipates to initiate this trial in 2015.
- 22 May 2014 New trial record
- 01 May 2014 According to a Merrimack Pharmaceuticals media release, a phase II clinical study for MM-151 will be initiated in 2014.